Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|March 30, 2016
DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinVeniero Gambaro, Gabriella Roda, Giacomo Luca Visconti, et al.
Haematologica|March 16, 2006
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicityErcole Brusamolino, Chiara Rusconi, Luigi Montalbetti, et al.
Haematologica|October 9, 2002
A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myelomaAlessandro Corso, Luca Arcaini, Sabrina Caberlon, et al.
Hematology Reports|July 5, 2021
Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patientsElisa Lucchini, Chiara Rusconi, Mario Levis, et al.
British Journal of Haematology|February 23, 2019
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)Chiara Rusconi, Antonella Anastasia, Annalisa Chiarenza, et al.
Leukemia & Lymphoma|June 7, 2024
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care)Ombretta Annibali, Alessia Castellino, Natalia Cenfra, et al.
Haematologica|November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkersFrancesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
American Journal of Hematology|December 16, 2014
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphomaLuca Arcaini, Lucia Morello, Alessandra Tucci, et al.
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Pageof 6